Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endovascular Superselective Embolization of the Branches of the Renal Artery in the Treatment of Renal Angiomyolipoma: a Prospective Cohort Study

NCT07538908 is registered in ClinicalTrials.gov with Botkin Hospital as lead sponsor.

NCT NCT07538908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07538908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endovascular Superselective Embolization of the Branches of the Renal Artery in the Treatment of Renal Angiomyolipoma: a Prospective Cohort Study
Lead sponsor
Botkin Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
April 6, 2026
Completion date
May 10, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

selective endovascular embolization of kidney artery